Ultra-Sensitive NGS Liquid Biopsy
Cost-Effective Discovery
Benchmark-setting Liquid Biopsy Technology: OncoBEAM allows for the detection of important mutations from 0.02% to 0.04% allele frequency to ensure reliable molecular information.
Support for All Phases of Clinical Development: Sysmex Inostics specializes in purpose-designed, ultra-sensitive tests capable of detecting genetic alterations at very low mutant allele frequencies.
